rolofylline has been researched along with dipyridamole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
| Cronstein, BN; He, W; Mazumder, A; Wilder, T | 1 |
2 other study(ies) available for rolofylline and dipyridamole
| Article | Year |
|---|---|
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma.
Topics: Acetamides; Adenosine; Aminopyridines; Animals; Bone and Bones; Cell Differentiation; Cells, Cultured; Dipyridamole; Female; Humans; Mice; Mice, Knockout; Multiple Myeloma; Osteocalcin; Osteoclasts; Purinergic P1 Receptor Agonists; Purines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Reverse Transcriptase Polymerase Chain Reaction; Xanthines | 2013 |